Correlation Between Cingulate Warrants and Unicycive Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Unicycive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Unicycive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and Unicycive Therapeutics, you can compare the effects of market volatilities on Cingulate Warrants and Unicycive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Unicycive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Unicycive Therapeutics.
Diversification Opportunities for Cingulate Warrants and Unicycive Therapeutics
-0.65 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Cingulate and Unicycive is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Unicycive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unicycive Therapeutics and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Unicycive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unicycive Therapeutics has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Unicycive Therapeutics go up and down completely randomly.
Pair Corralation between Cingulate Warrants and Unicycive Therapeutics
Assuming the 90 days horizon Cingulate Warrants is expected to generate 9.56 times less return on investment than Unicycive Therapeutics. In addition to that, Cingulate Warrants is 2.7 times more volatile than Unicycive Therapeutics. It trades about 0.01 of its total potential returns per unit of risk. Unicycive Therapeutics is currently generating about 0.14 per unit of volatility. If you would invest 42.00 in Unicycive Therapeutics on August 28, 2024 and sell it today you would earn a total of 13.00 from holding Unicycive Therapeutics or generate 30.95% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 97.67% |
| Values | Daily Returns |
Cingulate Warrants vs. Unicycive Therapeutics
Performance |
| Timeline |
| Cingulate Warrants |
| Unicycive Therapeutics |
Cingulate Warrants and Unicycive Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cingulate Warrants and Unicycive Therapeutics
The main advantage of trading using opposite Cingulate Warrants and Unicycive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Unicycive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unicycive Therapeutics will offset losses from the drop in Unicycive Therapeutics' long position.| Cingulate Warrants vs. Eliem Therapeutics | Cingulate Warrants vs. HCW Biologics | Cingulate Warrants vs. Scpharmaceuticals | Cingulate Warrants vs. Milestone Pharmaceuticals |
| Unicycive Therapeutics vs. Eliem Therapeutics | Unicycive Therapeutics vs. HCW Biologics | Unicycive Therapeutics vs. Scpharmaceuticals | Unicycive Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |